Compare Vivakor, Inc. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -252.63% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
- OPERATING CASH FLOW(Y) Lowest at USD -4.34 MM
- RAW MATERIAL COST(Y) Grown by 3,595.83% (YoY)
- DEBTORS TURNOVER RATIO(HY) Lowest at 9.18 times
2
Risky - Negative EBITDA
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
USD 2 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.66
-79.86%
0.02
Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Sep 2025)
Net Profit:
-34 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-98.66%
0%
-98.66%
6 Months
-99.39%
0%
-99.39%
1 Year
-99.47%
0%
-99.47%
2 Years
-99.23%
0%
-99.23%
3 Years
-99.5%
0%
-99.5%
4 Years
-99.9%
0%
-99.9%
5 Years
-99.9%
0%
-99.9%
Vivakor, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
158.73%
EBIT Growth (5y)
-252.63%
EBIT to Interest (avg)
-4.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
1.01
Tax Ratio
0.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.06%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.34
EV to EBIT
-5.92
EV to EBITDA
-53.69
EV to Capital Employed
0.59
EV to Sales
0.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.96%
ROE (Latest)
-22.36%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (1.56%)
Foreign Institutions
Held by 3 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
17.00
29.10
-41.58%
Operating Profit (PBDIT) excl Other Income
-6.00
0.10
-6,100.00%
Interest
14.80
4.40
236.36%
Exceptional Items
-10.00
-1.70
-488.24%
Consolidate Net Profit
-34.30
-12.50
-174.40%
Operating Profit Margin (Excl OI)
-531.80%
-232.90%
-29.89%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -41.58% vs -21.98% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -174.40% vs -66.67% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
89.80
59.30
51.43%
Operating Profit (PBDIT) excl Other Income
-2.00
-2.40
16.67%
Interest
4.80
4.00
20.00%
Exceptional Items
-8.50
-1.20
-608.33%
Consolidate Net Profit
-26.40
-10.80
-144.44%
Operating Profit Margin (Excl OI)
-148.80%
-106.70%
-4.21%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 51.43% vs 111.03% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -144.44% vs 46.53% in Dec 2023
About Vivakor, Inc. 
Vivakor, Inc.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






